Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells

Aromatase inhibitor (AI) resistance is a major obstacle in the treatment of estrogen receptor-positive breast cancer. Everolimus (EVE) ameliorates AI-resistant breast cancer and is therefore used in cancer treatment. However, some patients show resistance to EVE. Here, we used 30 clones of long-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Takanori, Hikichi, Masahiro, Yukitake, Jun, Wakatsuki, Toru, Nishio, Eiji, Utsumi, Toshiaki, Harada, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955115/
https://www.ncbi.nlm.nih.gov/pubmed/29805747
http://dx.doi.org/10.18632/oncotarget.25217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955115/
https://www.ncbi.nlm.nih.gov/pubmed/29805747
http://dx.doi.org/10.18632/oncotarget.25217

Ejemplares similares